ResearchMoz

Lumbar Spinal Stenosis Global Clinical Trials Review, H2, 2014

GlobalData
Published Date » 2014-07-21
No. Of Pages » 67
Lumbar Spinal Stenosis Global Clinical Trials Review, H2, 2014  Summary  GlobalData's clinical trial report, Lumbar Spinal Stenosis Global Clinical Trials Review, H2, 2014" provides data on the Lumbar Spinal Stenosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Lumbar Spinal Stenosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Lumbar Spinal Stenosis. This report is built using data and information sourced from proprietary...
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Lumbar Spinal Stenosis 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Central and South America 12
Clinical Trials by G7 Countries: Proportion of Lumbar Spinal Stenosis to Central Nervous System Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by E7 Countries: Proportion of Lumbar Spinal Stenosis to Central Nervous System Clinical Trials 16
Clinical Trials by Phase in E7 Countries 17
Clinical Trials by Phase 18
In Progress Trials by Phase 19
Clinical Trials by Trial Status 20
Clinical Trials by End Point Status 21
Unaccomplished Trials of Lumbar Spinal Stenosis 22
Subjects Recruited Over a Period of Time 23
Clinical Trials by Sponsor Type 24
Prominent Sponsors 25
Top Companies Participating in Lumbar Spinal Stenosis Therapeutics Clinical Trials 26
Prominent Drugs 27
Clinical Trial Profiles 28
Clinical Trial Overview of Top Companies 28
Sucampo Pharmaceuticals, Inc. 28
Clinical Trial Overview of Sucampo Pharmaceuticals, Inc. 28
United Therapeutics Corporation 29
Clinical Trial Overview of United Therapeutics Corporation 29
Mesoblast Limited 30
Clinical Trial Overview of Mesoblast Limited 30
KT&G Corporation 31
Clinical Trial Overview of KT&G Corporation 31
Kaken Pharmaceutical Co., Ltd. 32
Clinical Trial Overview of Kaken Pharmaceutical Co., Ltd. 32
Clinical Trial Overview of Top Institutes / Government 33
Keio University 33
Clinical Trial Overview of Keio University 33
Hamamatsu University School of Medicine 34
Clinical Trial Overview of Hamamatsu University School of Medicine 34
National University Of Health Sciences 35
Clinical Trial Overview of National University Of Health Sciences 35
University of Manitoba 36
Clinical Trial Overview of University of Manitoba 36
Asan Medical Center 37
Clinical Trial Overview of Asan Medical Center 37
Kobe University 38
Clinical Trial Overview of Kobe University 38
Yonsei University 39
Clinical Trial Overview of Yonsei University 39
Ohio State University 40
Clinical Trial Overview of Ohio State University 40
Leiden University Medical Center 41
Clinical Trial Overview of Leiden University Medical Center 41
Emory University 42
Clinical Trial Overview of Emory University 42
Five Key Clinical Profiles 43
Appendix 65
Abbreviations 65
Definitions 65
Research Methodology 66
Secondary Research 66
About GlobalData 67
Contact Us 67
Disclaimer 67
Source 67

List of Tables
Lumbar Spinal Stenosis Therapeutics, Global, Clinical Trials by Region, 2014* 6
Lumbar Spinal Stenosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Lumbar Spinal Stenosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Lumbar Spinal Stenosis Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 9
Lumbar Spinal Stenosis Therapeutics Clinical Trials, Europe, Top Countries, 2014* 10
Lumbar Spinal Stenosis Therapeutics Clinical Trials, North America, Top Countries, 2014* 11
Lumbar Spinal Stenosis Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 12
Proportion of Lumbar Spinal Stenosis to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 13
Lumbar Spinal Stenosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14
Lumbar Spinal Stenosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15
Proportion of Lumbar Spinal Stenosis to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 16
Lumbar Spinal Stenosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 17
Lumbar Spinal Stenosis Therapeutics, Global, Clinical Trials by Phase, 2014* 18
Lumbar Spinal Stenosis Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 19
Lumbar Spinal Stenosis Therapeutics, Global, Clinical Trials by Trial Status, 2014* 20
Lumbar Spinal Stenosis Therapeutics Clinical Trials, Global, by End Point Status, 2014* 21
Lumbar Spinal Stenosis Therapeutics, Global, Terminated Clinical Trials, 2014* 22
Lumbar Spinal Stenosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 23
Lumbar Spinal Stenosis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 24
Lumbar Spinal Stenosis Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 25
Lumbar Spinal Stenosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 26
Lumbar Spinal Stenosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 27
Lumbar Spinal Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Sucampo Pharmaceuticals, Inc., 2014* 28
Lumbar Spinal Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by United Therapeutics Corporation, 2014* 29
Lumbar Spinal Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Mesoblast Limited, 2014* 30
Lumbar Spinal Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by KT&G Corporation, 2014* 31
Lumbar Spinal Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Kaken Pharmaceutical Co., Ltd., 2014* 32
Lumbar Spinal Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Keio University, 2014* 33
Lumbar Spinal Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Hamamatsu University School of Medicine, 2014* 34
Lumbar Spinal Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by National University Of Health Sciences, 2014* 35
Lumbar Spinal Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Manitoba, 2014* 36
Lumbar Spinal Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Asan Medical Center, 2014* 37
Lumbar Spinal Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Kobe University, 2014* 38
Lumbar Spinal Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Yonsei University, 2014* 39
Lumbar Spinal Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Ohio State University, 2014* 40
Lumbar Spinal Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Leiden University Medical Center, 2014* 41
Lumbar Spinal Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Emory University, 2014* 42

List of Figures
Lumbar Spinal Stenosis Therapeutics, Global, Clinical Trials by Region (%), 2014* 6
Lumbar Spinal Stenosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Lumbar Spinal Stenosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Lumbar Spinal Stenosis Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014* 9
Lumbar Spinal Stenosis Therapeutics Clinical Trials, Europe, Top Countries (%), 2014* 10
Lumbar Spinal Stenosis Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 11
Proportion of Lumbar Spinal Stenosis to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 13
Lumbar Spinal Stenosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14
Lumbar Spinal Stenosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15
Proportion of Lumbar Spinal Stenosis to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 16
Lumbar Spinal Stenosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 17
Lumbar Spinal Stenosis Therapeutics, Global, Clinical Trials by Phase (%), 2014* 18
Lumbar Spinal Stenosis Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 19
Lumbar Spinal Stenosis Therapeutics, Global, Clinical Trials by Trial Status, 2014* 20
Lumbar Spinal Stenosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 23
Lumbar Spinal Stenosis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 24
Lumbar Spinal Stenosis Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 25
Lumbar Spinal Stenosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 26
Lumbar Spinal Stenosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 27
GlobalData Methodology 66

List of Tables

NA

List of Figures

NA

Upcoming Reports:

Oil and Gas Measuring Instrumentation Market - Global Industry Analysis, Size, Share, Trends, Analysis, Growth and Forecast 2014 - 2020
By - Transparency Market Research
Increasing demand of oil and gas coupled with decreasing oil and gas reserves are expected to boost demand for the global oil and gas measuring instrumentation market. Additional investment is required to achieve balance between above alternatives and further increase efficient extraction of the oil and gas. Instrumentation in the oil and gas industry introduces to the usage of control systems for accomplishment of various activities with minimal human interventions. Oil and gas supply and demand imbalance requires the implementation of oil and gas measuring instrumentation in the...
Customer Relationship Management (CRM) Outsourcing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2014 - 2020
By - Transparency Market Research
Outsourcing is a process where an organization selects an efficient third party service provider to effectively manage and operate its customer relationship management unit. Outsourcing of the CRM activities has emerged as a promising solution to meet increasing demand for quality CRM activities and rising costs associated with it. The CRM industry is in the process of revolutionizing itself with the addition of new services offerings such as modern communication and social media platforms. In addition, the CRM activities, which provide flexibility for both clients and workers, are...
Cardiac Ablation Devices Market- Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020
By - Transparency Market Research
Ablation is a procedure that involves removal of surface with the help of chemical or laser. Cardiac ablation involves ablation of cardiac tissues, and is a minimally invasive procedure done with the help of a bundle of catheters. The procedure depends upon physical condition and malaise faced by the patient. Cardiac ablation is used to treat conditions of cardiac arrhythmias, viz. tachycardia (supraventricular/atrial), atrial fibrillation (paroxysmal/intermittent), atrial flutter and WPW (Wolff-Parkinson-White) syndrome. Cardiac arrhythmia and similar disorders arise as a result of...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Pepsi Limon, A Brand New Addition to the Pepsi Portfolio
May 22, 2015  
To add a new dose of excitement to its cola offering, Pepsi has come up with the all new Pepsi Limon. This is a new flavored cola, which according to the company is manufactured with just the appropriate amount of real lime juice. The idea for the drink was inspired from the escalating preference of the Hispanic consumers. To satisfy the taste urges of the consumers, the new Pepsi Limon will...
Chinese Everbright Healthcare Fund to Acquire U.S. Firm Ambrx
May 22, 2015  
A group led by Chinese healthcare fund Everbright has chalked out details to buy U.S. based biotechnology firm Ambrx for an amount which in undisclosed. The deal, recently announces, is inclusive of other healthcare companies in mainland which are WuXi Pharma Tech and Shanghai Fosun Pharmaceutical, and investment company HOPU Investments.  The deal, which requires...
India’s Auto Exports Register Record High Figures in 2014-15
May 21, 2015  
In the fiscal year 2014-15, Indian factories exported a record number of 3.5 million vehicles, which is 15% higher than what they managed a year back. However, domestic sales rose by only 5% since last financial year, with 2.6 million units being sold.  Exports of utility vehicles, commercial vehicles, cars and two- wheelers have increased every year since 2000. But domestic car...
Turkey’s Labor Dispute Affects Ford’s Production
May 21, 2015  
With the ongoing labor dispute in Turkey, Ford’s Turkish manufacturing facility has been hit. Ford Otosan, a joint venture between the company and Turkey’s Koc Holding, mentioned that due to supply problems, production has been temporary stalled at its plants located at Yenikoy and Golcuk in northwestern part of the country. Earlier this week, production at Tofas and Oyak Renault,...
International Automakers Slashing Prices in China
May 21, 2015  
With a slowing Chinese economy, the international automakers are cutting prices of vehicles to be sold in the nation. This has hit the profit margins of the automakers who are struggling with a slowdown in demand.  Last week saw Ford Motor Co. and General Motors slashing their prices on Chinese models. It closely follows rival Volkswagen AG’s move last month to offer...